Ibuver (Ibuprofen D,l-Lysinate)

The lysinate salt of ibuprofen acts by non‑selectively inhibiting COX‑1 and COX‑2 enzymes, which decreases the synthesis of prostaglandins. Lower prostaglandin levels diminish peripheral pain signaling, suppress fever generation in the hypothalamus, and limit inflammatory exudate formation.

The appropriate dose of Ibuver is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Patients should follow the prescriber’s instructions and never adjust the dose on their own.

Safety of ibuprofen D,l‑lysinate in pregnancy or lactation has not been definitively established. It should only be used when the potential benefit outweighs the risk, and after consultation with a qualified healthcare provider.

To request Ibuver, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ibuver uses the lysinate salt of ibuprofen, which can improve aqueous solubility and may allow faster absorption compared with standard ibuprofen tablets. Therapeutic efficacy and safety profile remain comparable to other ibuprofen products when used at equivalent doses.

Store Ibuver at ambient temperature, preferably below 25 °C, in the original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiry date.

Ibuver is taken orally with a full glass of water. It may be taken with or without food; however, taking it with food can reduce the likelihood of gastrointestinal discomfort.

Serious risks include gastrointestinal ulceration or bleeding, acute kidney injury, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, and cardiovascular events like myocardial infarction or stroke. Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, blood in stool, sudden swelling, or difficulty breathing.

Ibuver should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe renal or hepatic impairment, uncontrolled heart failure, and in the third trimester of pregnancy unless specifically advised by a physician.